[go: up one dir, main page]

NO20010532L - Antioksidant, antiproliferativ sammensetning som innbefatter et karnitin og et karotenoid - Google Patents

Antioksidant, antiproliferativ sammensetning som innbefatter et karnitin og et karotenoid

Info

Publication number
NO20010532L
NO20010532L NO20010532A NO20010532A NO20010532L NO 20010532 L NO20010532 L NO 20010532L NO 20010532 A NO20010532 A NO 20010532A NO 20010532 A NO20010532 A NO 20010532A NO 20010532 L NO20010532 L NO 20010532L
Authority
NO
Norway
Prior art keywords
carotenoid
carnitine
antioxidant
composition
dietary supplement
Prior art date
Application number
NO20010532A
Other languages
English (en)
Other versions
NO20010532D0 (no
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of NO20010532D0 publication Critical patent/NO20010532D0/no
Publication of NO20010532L publication Critical patent/NO20010532L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Cardiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

En sammensetning er vist som innbefatter som kjennetegnende aktive bestanddeler, propionyl L-karnitin og minst ett karotenoid, typisk lykopenet ekstrahert fra tomat for forebygging og/eller terapeutisk behandling av forskjellige forandringer og patologiske tilstander indusert av frie radikaler og av lipoperoksidasjonsfenomener som kan ta form av et kosttilskudd, koststøtte eller av et reelt legemiddel.
NO20010532A 1998-08-03 2001-01-31 Antioksidant, antiproliferativ sammensetning som innbefatter et karnitin og et karotenoid NO20010532L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998RM000516A IT1302125B1 (it) 1998-08-03 1998-08-03 Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide
PCT/IT1999/000251 WO2000007581A2 (en) 1998-08-03 1999-07-29 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid

Publications (2)

Publication Number Publication Date
NO20010532D0 NO20010532D0 (no) 2001-01-31
NO20010532L true NO20010532L (no) 2001-03-20

Family

ID=11406082

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010532A NO20010532L (no) 1998-08-03 2001-01-31 Antioksidant, antiproliferativ sammensetning som innbefatter et karnitin og et karotenoid

Country Status (21)

Country Link
EP (1) EP1102584A2 (no)
JP (1) JP2002522382A (no)
KR (1) KR20010072146A (no)
CN (1) CN1311674A (no)
AR (1) AR021172A1 (no)
AU (1) AU5064199A (no)
BR (1) BR9912703A (no)
CA (1) CA2338035A1 (no)
EE (1) EE200100052A (no)
HK (1) HK1039062A1 (no)
HU (1) HUP0102807A2 (no)
IL (1) IL140797A0 (no)
IS (1) IS5816A (no)
IT (1) IT1302125B1 (no)
MA (1) MA26666A1 (no)
NO (1) NO20010532L (no)
PL (1) PL346161A1 (no)
SK (1) SK1252001A3 (no)
TN (1) TNSN99152A1 (no)
TR (1) TR200100333T2 (no)
WO (1) WO2000007581A2 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100784120B1 (ko) 2000-06-02 2007-12-12 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 에틸렌디시스테인(ｅｃ)-약물 접합체
US6923960B2 (en) 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
KR100523562B1 (ko) 2001-10-29 2005-10-25 한국과학기술연구원 손바닥선인장 추출물 및 이로부터 분리된 화합물을함유하는 신경세포 보호용 조성물
JP4527938B2 (ja) * 2002-07-23 2010-08-18 オルビス株式会社 抗酸化用の経口投与組成物
JP4334189B2 (ja) * 2002-07-30 2009-09-30 カゴメ株式会社 Ａｇｅ生成阻害剤
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
ATE423109T1 (de) 2003-04-14 2009-03-15 Nippon Soda Co Diaminderivat, herstellungsverfahren und antioxidations-arzneimittel
US9050378B2 (en) 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
BRPI0507253A (pt) * 2004-01-28 2007-06-26 Nestec Sa composição nutricional para melhorar as condições da pele e prevenir doenças de pele
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
RU2619342C1 (ru) * 2016-02-24 2017-05-15 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Препарат для профилактики и лечения свободнорадикальной патологии у животных
CN113491687A (zh) * 2020-04-02 2021-10-12 常州高新技术产业开发区三维工业技术研究所有限公司 一种解毒药物组合物及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
EP0400547A1 (en) * 1989-06-02 1990-12-05 Abbott Laboratories Parenteral nutrition product
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US5667791A (en) * 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito

Also Published As

Publication number Publication date
SK1252001A3 (en) 2001-08-06
WO2000007581A2 (en) 2000-02-17
IL140797A0 (en) 2002-02-10
AU5064199A (en) 2000-02-28
EE200100052A (et) 2002-06-17
WO2000007581A3 (en) 2000-05-11
IT1302125B1 (it) 2000-07-31
HUP0102807A2 (hu) 2002-03-28
NO20010532D0 (no) 2001-01-31
TNSN99152A1 (fr) 2005-11-10
BR9912703A (pt) 2001-05-02
CA2338035A1 (en) 2000-02-17
ITRM980516A1 (it) 2000-02-03
IS5816A (is) 2001-01-16
ITRM980516A0 (it) 1998-08-03
AR021172A1 (es) 2002-07-03
KR20010072146A (ko) 2001-07-31
TR200100333T2 (tr) 2001-07-23
PL346161A1 (en) 2002-01-28
MA26666A1 (fr) 2004-12-20
JP2002522382A (ja) 2002-07-23
CN1311674A (zh) 2001-09-05
EP1102584A2 (en) 2001-05-30
HK1039062A1 (zh) 2002-04-12

Similar Documents

Publication Publication Date Title
NO20010954L (no) Antioksidantsammensetning som innbefatter acetyl L-karnitin og <alfa>-lipoidsyre
NO20010532L (no) Antioksidant, antiproliferativ sammensetning som innbefatter et karnitin og et karotenoid
DK0787489T3 (da) Sammensætning, der indeholder propionyl-L-carnitin og hydroxycitronsyre eller pantothensyre
CA2334875A1 (en) Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome
DK0659402T3 (da) Formuleringer indeholdende carotenoider og procarotenoider kombineret med polyphenoler til forebyggelse af beskadigelser som følge af abnorm produktion af frie radikaler
NO20035473D0 (no) Oralt administrerte doseringsformer av GABA-analogprodrugs som har reduserttoksisitet
ATE406893T1 (de) Pharmazeutische zusammensetzung (kit) enthaltend dihydropyridinonverbindungen und eine verbindung mit immunmodulatorischer (oder antiinflammatorischer) wirkung und ihre verwendung
ES2137628T3 (es) Derivados de estilbeno y composiciones farmaceuticas que los contienen.
EP1072254A4 (en) FOOD, ORAL COMPOSITIONS AND MEDICAL COMPOSITIONS FOR PREVENTING OR TREATING PERIODONTOSIS AND PROCESS FOR PREVENTING OR TREATING PERIODONTOSIS
DK0465343T3 (da) Farmaceutisk eller kosmetisk præparat indeholdende en kombination af et retinoid og en sterol
BR9916197A (pt) Método para o tratamento de isquemia cerebral e uso de eritropoietina ou derivados de eritropoietina para o tratamento de isquemia cerebral
NO20006430L (no) Neurobeskyttende sammensetning for forhindring og/eller behandling av nerve- og atferdsforandringer på grunn av angsttilstander eller depresjoner
NO20011693L (no) Kombinasjon av karnitiner og resveratrol for forebygging eller behandling av cerebrale og aldringsforstyrrelser
DK0773022T3 (da) Farmaceutisk sammensætning til behandling af rhinitis indeholdende sympathomimetika og pantothenol og/eller pantothensyre
DK0951909T3 (da) Kombinationspræparat omfattende en L-carnitin eller en alkanoyl-L-carnitin, en glycosaminoglycan og/eller bestanddel deraf
NO20021640L (no) Sammensetning til forebygging og/eller behandling av kretslöpsykdommer som omfatter derivater av L-karnitin ogekstrakter av Gingo biloba
BR0009859A (pt) Composições fungicidas para proteção das frutas, processo de tratamento das frutas e frutas tratadas
WO2000000183A3 (en) Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose comprising acetyl-l-carnitine and a catechin
TR200101344T2 (tr) Propionil L-karnitinden ve bir flavonoid'den oluşan antioksidan bileşim
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
NO20011430D0 (no) Anvendelse av organofosforforbindelser for fremstilling av medikamenter for terapeutisk og profylaktisk behandling av infeksjoner, eller som et fungicid, baktericid eller herbicid for planter
NO20022288L (no) Sammensetning til forebygging og/eller behandling av forstyrrelser forårsaket av abnorm lipid metabolisme, sominnbefatter propionyl L-karnitin og kitosan
AR023644A1 (es) 3-aril-pirazoles substituidos, procedimiento para su obtencion, procedimiento para la lucha contra plantas indeseables, empleo de los mismos contra plantasindeseables y/o como fungicida, y composicion para el tratamiento de plantas
AU2002333535A1 (en) Treatment of excessive radiation (e.g. sunburn) exposure
NO20023117D0 (no) Sammensetning for forebygging og/eller behandling av lipidmetabolismeforstyrrelser og allergiske former

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application